COVID-19感染后重症监护后综合征与慢性疼痛的早期照护、治疗教育与心理干预计划(PAIN-COVID):随机对照试验的原理与研究设计
PAIN-COVID试验是一项单中心、随机、对照、患者盲法的优效性试验,旨在评估基于早期治疗教育与心理干预的特定照护方案能否改善COVID-19危重患者出院后6个月的健康相关生活质量。计划入组102例患者(每组51例),主要终点为出院后6个月的健康相关生活质量。
要点
- 针对COVID-19危重患者PICS和慢性疼痛的早期干预随机对照试验。
- 主要终点为出院后6个月健康相关生活质量,计划样本量102例。
- 干预方案基于早期治疗教育与心理干预,对照为标准照护。
核心结论
- 该试验旨在验证基于早期治疗教育与心理干预的特定照护方案优于标准照护,可改善COVID-19危重患者出院后6个月的健康相关生活质量。
研究设计与样本
- 单中心、随机、对照、患者盲法、优效性试验,两组平行,按1:1分配。
- 计划样本量102例(每组51例),考虑20%失访率,估算样本量为84例(每组42例)。
关键数值与推荐
- 主要终点为出院后6个月的健康相关生活质量。
- 次要终点包括出院后3个月和6个月的健康相关生活质量、慢性疼痛发生率、功能受限程度、焦虑、抑郁和创伤后应激综合征发生率。
临床怎么用
- 若试验证实有效,可推动在COVID-19危重患者早期阶段实施治疗教育与心理干预计划,以管理PICS和慢性疼痛。
局限性
- 单中心设计可能影响结果的外推性。
- 本文为研究方案,尚未报告结局数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Critically ill patients with COVID-19 are an especially susceptible population to develop post-intensive care syndrome (PICS) due to acute respiratory distress syndrome (ARDS). Patients can suffer acute severe pain and may have long-term mental, cognitive, and functional health deterioration after discharge. However, few controlled trials are evaluating interventions for the prevention and treatment of PICS. The study hypothesis is that a specific care program based on early therapeutic education and psychological intervention improves the quality of life of patients at risk of developing PICS and chronic pain after COVID-19. The primary objective is to determine whether the program is superior to standard-of-care on health-related quality of life at 6 months after hospital discharge. The secondary objectives are to determine whether the intervention is superior to standard-of-care on health-related quality of life, incidence of chronic pain and degree of functional limitation, incidence of anxiety, depression, and post-traumatic stress syndrome at 3 and 6 months after hospital discharge. METHODS: The PAINCOVID trial is a unicentric randomized, controlled, patient-blinded superiority trial with two parallel groups. The primary endpoint is the health-related quality of life at 6 months after hospital discharge, and randomization will be performed with a 1:1 allocation ratio. This paper details the methodology and statistical analysis plan of the trial and was submitted before outcome data were available. The estimated sample size is 84 patients, 42 for each arm. Assuming a lost to follow-up rate of 20%, a sample size of 102 patients is necessary (51 for each arm). DISCUSSION: This is the first randomized clinical trial assessing the effectiveness of an early care therapeutic education, and psychological intervention program for the management of PICS and chronic pain after COVID-19. The intervention will serve as proof of the need to implement early care programs at an early stage, having an incalculable impact given the current scenario of the pandemic. TRIAL REGISTRATION: This study is being conducted in accordance with the tenets of the Helsinki Declaration and has been approved by the authors' institutional review board Comité Ético de Investigación Clínica del Hospital Clínic de Barcelona (approval number: HCB/2020/0549) and was registered on May 9, 2020, at clinicaltrials.gov ( NCT04394169 ).
引用
- Ojeda A, Calvo A, Cuñat T, et al. Rationale and study design of an early care, therapeutic education, and psychological intervention program for the management of post-intensive care syndrome and chronic pain after COVID-19 infection (PAIN-COVID): study protocol for a randomized controlled trial. Trials. 2021. PMID: 34303381. doi:10.1186/s13063-021-05463-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。